Scientists and formulators continue to scour land and sea for the world's most powerful nutritional ingredients. Here, Paul Garrott, CEO and managing director of Marinova, discusses why fucoidan--a highly bioactive seaweed-derived ingredient holds much promise for the future of dietary supplements. In nature, it protects seaweed from environmental factors; learn what it does for human health during this episode of SupplySide Stories.
About our speaker:
Paul Garrott, CEO and managing director, Marinova
Paul Garrott has been CEO of Marinova since 2003. His strategic approach to innovation and commercialization has taken the company from start-up to global success. Paul’s commitment to marine science and his longstanding history of investing in innovative research has seen Maritech® fucoidan extracts rise to the forefront of natural therapeutics.
"In terms of where it fits in the market, fucoidan fits everywhere; there's extensive scientific evidence supporting the diverse bioactivities of fucoidan." - Paul Garrott, CEO and managing director, Marinova
More information on Marinova can be found at SupplySide Connect
